课题基金 / 基金详情

项目摘要

项目成果

Suzanne Walker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): O-GlcNAc transferase (OGT) is an essential mammalian enzyme that catalyzes a unique post-translational modification, O-GlcNAcylation. O-GlcNAcylation has been shown to modulate insulin signaling, gluconeogenesis, and other pathways connected to glucose metabolism. Hyper-O-GlcNAcylation leads to widespread transcriptional changes and has been linked to diabetic complications, cancer, and other pathologies. Therefore, it has been suggested that OGT could be a therapeutic target. A better understanding of the structure and function of OGT is critical for dissecting its biological roles, and small molecule inhibitors are widely sought by the scientific community. The goals of this proposal are i) to supply the structural basis for rational experiments to dissect the biochemical and cellular functions of OGT, ii) to provide validated small molecule inhibitors for use as cellular probes of OGT function, and iii) to develop a proteome-wide substrate profiling approach to identify OGT features required for substrate selection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploiting membrane targets to overcome antibiotic resistance
  • 批准号:
    10699952
  • 项目类别:
  • 资助金额:
    $251.52万
  • 财政年份:
    2022
  • 负责人:
    Suzanne Walker
  • 依托单位:
Administrative Core
  • 批准号:
    10699953
  • 项目类别:
  • 资助金额:
    $13.13万
  • 财政年份:
    2022
  • 负责人:
    Suzanne Walker
  • 依托单位:
Project 2: Targeting Gram-positive Cell Envelope Assembly
  • 批准号:
    10699955
  • 项目类别:
  • 资助金额:
    $73.23万
  • 财政年份:
    2022
  • 负责人:
    Suzanne Walker
  • 依托单位:
Subproject 1 Compounds and Strategies for Treating MRSA and VRE
海外基金